Production (Stage)
Quest PharmaTech Inc.
QPT.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 94.54% | 42.87% | 96.70% | 95.47% | 94.12% |
| Total Depreciation and Amortization | -- | -- | -100.00% | -100.00% | -42.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -104.24% | -43.36% | -97.41% | -96.27% | -94.81% |
| Change in Net Operating Assets | -1,201.92% | -165.98% | -168.56% | 130.51% | 94.46% |
| Cash from Operations | 7.26% | -48.09% | -22.71% | 12.84% | 20.54% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 660.78% | 660.78% | 660.78% |
| Cash from Financing | -- | -- | 635.07% | 503.81% | 1,097.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -204.76% | -247.86% | 125.20% | 153.63% | 160.69% |